Imagion Biosystems Ltd IBXXF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.03
- Day Range
- $0.01–0.01
- 52-Week Range
- $0.01–0.04
- Bid/Ask
- $0.01 / $0.03
- Shares Outstanding
- 4.97B
- Market Cap
- $5.89M
- Volume/Avg
- 400,000 / 167,667
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Imagion Biosystems Ltd operates in the field of non-invasive detection of specific solid tumor cancers by use of magnetic nanoparticles. Its principal continuing activities consisted of Nanotechnology; Biotechnology; Cancer Diagnostics; and Medical Imaging using Magnetic Resonance and Superparamagnetic Relaxometry. The company only operating segment - Research and Development. Its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics, and medical imaging using Superparamagnetic Relaxometry. In addition, the company is engaged in the research and development of its clinical phase lead product which is intended for the detection and staging of metastatic HER2 breast cancer. The company operates in Australia and the USA, with revenue from Australia.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- —
- Website
- https://imagionbiosystems.com
Valuation
|
Metric
|
IBXXF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
IBXXF
|
|---|---|
Quick Ratio | 0.44 |
Current Ratio | 0.48 |
Interest Coverage | — |
Quick Ratio
IBXXF
Profitability
|
Metric
|
IBXXF
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
IBXXF
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|#$cj<%KP | LOCK|Kk | $214B | |||
| Danaher Corp
DHR
| LOCK|WT%>s?n | LOCK|V!z | $140B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|>?gcq#@& | LOCK|ZP | $46B | |||
| Agilent Technologies Inc
A
| LOCK|TZlhVzb | LOCK|lKx | $40B | |||
| Waters Corp
WAT
| LOCK|fbHM!P& | LOCK|cy | $39B | |||
| IQVIA Holdings Inc
IQV
| LOCK|!>&g&zx | LOCK|k$<H | $39B | |||
| Illumina Inc
ILMN
| LOCK|&jq&#y | LOCK|S%wh | $30B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|LMy?pM? | LOCK|<lMH< | $28B | |||
| Quest Diagnostics Inc
DGX
| LOCK|FPgdtZh | LOCK|@VRs# | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|!ZZK%ss | LOCK|%Qn@ | $25B |
United States